Production of novel NaN3-resistant creatine amidinohydrolase in recombinant Escherichia coli (vol 6, pg 248, 2015)

被引：3
|
作者：
Liu, Song [1 ,2 ,3 ]
Dai, Jun [1 ,2 ,3 ]
Kang, Zhen [1 ,2 ,3 ]
Li, Jianghua [1 ,2 ,3 ]
Chen, Jian [2 ,3 ]
Du, Guocheng [2 ,3 ]
机构：
[1] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China
[2] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China
[3] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Jiangsu, Peoples R China
来源：
BIOENGINEERED | 2015年 / 6卷 / 04期
关键词：
arthrobacter nicotianae; creatinase; escherichia coli; NaN3-resistance; HIGH-LEVEL SECRETION; PSEUDOMONAS-PUTIDA; CONSTRUCTION; PURIFICATION; EXPRESSION; CLONING; SYSTEM; GENE;
D O I：
10.1080/21655979.2015.1052919
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Creatinase (creatine amidinohydrolase), an important medical enzyme, has been used for clinical diagnosis of renal function because of its high substrate specificity. Recently, we successfully cloned a NaN3-resistant creatinase encoding gene from Arthrobacter nicotianae. By optimizing the cultivation process, we realized its high-level expression in Escherichia coli. In this addendum, production of this NaN3-resistant creatinase in Escherichia coli and future research were further discussed.
引用
收藏
页码：248 / 250
页数：3
相关论文
共 41 条
  • [31] Safety of 6'-sialyllactose (6'-SL) sodium salt produced by derivative strains of Escherichia coli BL21 (DE3) as a novel food pursuant to Regulation (EU) 2015/2283
    Turck, Dominique
    Bohn, Torsten
    Castenmiller, Jacqueline
    De Henauw, Stefaan
    Hirsch-Ernst, Karen Ildico
    Maciuk, Alexandre
    Mangelsdorf, Inge
    McArdle, Harry J.
    Naska, Androniki
    Pelaez, Carmen
    Pentieva, Kristina
    Siani, Alfonso
    Thies, Frank
    Tsabouri, Sophia
    Vinceti, Marco
    Cubadda, Francesco
    Frenzel, Thomas
    Heinonen, Marina
    Marchelli, Rosangela
    Neuhauser-Berthold, Monika
    Poulsen, Morten
    Maradona, Miguel Prieto
    Schlatter, Josef Rudolf
    van Loveren, Henk
    Colombo, Paolo
    Fernandez, Estefania Noriega
    Knutsen, Helle Katrine
    EFSA JOURNAL, 2022, 20 (12)
  • [32] Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli (vol 59, pg 4471, 2015)
    Johnson, James R.
    Johnston, Brian
    Kuskowski, Michael A.
    Sokurenko, Evgeni V.
    Tchesnokova, Veronika
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (09) : 5871 - 5871
  • [33] Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus (vol 6, pg 592, 2015)
    Ou, Changbo
    Zhang, Qiang
    Wang, Juan
    Wu, Guojiang
    Shi, Ningning
    He, Cheng
    Gao, Zengping
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [34] Screening of Selective Inhibitors of 1α, 25-Dihydroxyvitamin D3 24-Hydroxylase Using Recombinant Human Enzyme Expressed in Escherichia coli (vol 49, pg 10403, 2010)
    Zhu, Jinge
    Barycki, Rafal
    Chiellini, Grazia
    DeLuca, Hector F.
    BIOCHEMISTRY, 2011, 50 (30) : 6606 - 6606
  • [35] Immunization with a novel recombinant protein (YidR) reduced the risk of clinical mastitis caused by Klebsiella spp. and decreased milk losses and culling risk after Escherichia coli infections (vol 104, pg 4787, 2021)
    Tomazi, T.
    Tomazi, A. C. C. H.
    Silva, J. C. C.
    Bringhenti, L.
    Bravo, M. L. M. C.
    Rodrigues, M. X.
    Bicalho, R. C.
    JOURNAL OF DAIRY SCIENCE, 2021, 104 (06) : 7342 - 7342
  • [36] Genetic mutations potentially cause two novel NCF1 splice variants up-regulated in the mammary gland, blood and neutrophil of cows infected by Escherichia coli (vol 174, pg 24, 2015)
    Zhang, Zijing
    Wang, Xiuge
    Li, Rongling
    Ju, Zhihua
    Qi, Chao
    Zhang, Yan
    Guo, Fang
    Luo, Guojing
    Li, Qiuling
    Wang, Changfa
    Zhong, Jifeng
    Xu, Yinxue
    Huang, Jinming
    MICROBIOLOGICAL RESEARCH, 2015, 181 : 120 - 120
  • [37] Codon Optimization, Expression in Escherichia coli, and Immunogenicity of Recombinant Chinese Sacbrood Virus (CSBV) Structural Proteins VP1, VP2, and VP3 (vol 10, e0128486, 2015)
    Fei, Dongliang
    Zhang, Haochun
    Diao, Qingyun
    Jiang, Lili
    Wang, Qiang
    Zhong, Yi
    Fan, Zhaobin
    Ma, Mingxiao
    PLOS ONE, 2015, 10 (07):
  • [38] High-level expression and purification of recombinant huGM-CSF(9-127)/1L-6(29-184) fusion protein in Escherichia coli (Retraction of vol 42, pg 278, 2005)
    Sun Qiang-ming
    Jiang Hong-chao
    Xu Wei-ming
    Liu Xin
    Dai Chang-bai
    Sun Mao-sheng
    PROTEIN EXPRESSION AND PURIFICATION, 2007, 52 (02) : 486 - 486
  • [39] RETRACTED: High-level expression and purification of recombinant huGM-CSF (9-127)/IL-6 (29-184) fusion protein in Escherichia coli. (Retracted Article. See vol 42, pg 486, 2007)
    Sun, QM
    Jiang, HC
    Xu, WM
    Liu, X
    Dai, CB
    Sun, MS
    PROTEIN EXPRESSION AND PURIFICATION, 2005, 42 (02) : 278 - 285
  • [40] A HOMOLOGY MODEL OF THE 3-DIMENSIONAL STRUCTURE OF HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE BASED ON THE CRYSTAL-STRUCTURE OF THE C-TERMINAL DOMAIN OF THE ADA PROTEIN FROM ESCHERICHIA-COLI (VOL 10, PG 75, 1995)
    WIBLEY, JEA
    MCKIE, JH
    EMBREY, K
    MARKS, DS
    DOUGLAS, KT
    MOORE, MH
    MOODY, PCE
    ANTI-CANCER DRUG DESIGN, 1995, 10 (05): : 439 - 439
12345